Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q2 2015 · 10-Q
Revenue$457.78K$457.78K+92.3% vs Q2 2014 Net Income-$3.77M-$3.77MN/M vs Q2 2014 EPS Diluted-$0.02-$0.02— vs Q2 2014 Operating Income-$3,907,739— Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-853.6%
Net margin-823.7%
ended Jun 30, 2015 · filed Aug 12, 2015 · 43 d after period end